Literature DB >> 18418080

PDGF/VEGF system activation and angiogenesis following initial post ovariectomy meningeal microvessel loss.

Olga V Glinskii1, Tsghe W Abraha, James R Turk, Vladislav V Glinsky, Virginia H Huxley.   

Abstract

Recently we demonstrated that cessation of ovarian hormone production causes dramatic vascular remodeling in meningeal microvascular networks characterized by a significant microvessel loss. Further, even two months post ovariectomy (OVX), dura mater microvessels remain destabilized due to a decline in estrogen-mediated angiopoietin-1 (Ang-1) expression and Ang-1/Tie-2 signaling. Such destabilized microvessels could be susceptible to either further regression or angiogenesis. In this study, we tested the hypothesis that initial estrogen-dependent loss of meningeal microvessels following OVX triggers stromal and vascular hypoxic responses aiming at restoring dura microvasculature. We demonstrate that two months post OVX, there is an activation of the hypoxia-inducible factor-1alpha (HIF-1alpha) and PDGF/VEGF system in the dura mater stroma and microvasculature of experimental animals accompanied by a shift in the balance between PI3K and PLCgamma activity downstream of PDGF/VEGF signaling toward PI3K. It appears that the latter serves as a molecular switch favoring angiogenic responses rather than further regression of destabilized microvessels. Indeed, consistent with this idea, we have found a considerable angiogenic activity in meningeal microvascular networks that previously underwent regression. These results indicate that angioadaptation of meningeal microvessels in response to cessation of ovarian hormone production is not a unidirectional, but a very complex multi-stage process regulated on many levels. The implication of this study is that therapeutic interventions, including estrogen-based hormone replacement therapy, with physiological angioadaptation in postmenopausal or post OVX women need to be approached with the extreme caution.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18418080      PMCID: PMC3332329          DOI: 10.4161/cc.7.10.5819

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  18 in total

Review 1.  Angioadaptation: keeping the vascular system in shape.

Authors:  Andreas Zakrzewicz; Timothy W Secomb; Axel R Pries
Journal:  News Physiol Sci       Date:  2002-10

Review 2.  New insights regarding vessel regression.

Authors:  Eunok Im; Andrius Kazlauskas
Journal:  Cell Cycle       Date:  2006-09-15       Impact factor: 4.534

3.  Regulating angiogenesis at the level of PtdIns-4,5-P2.

Authors:  Eunok Im; Andrius Kazlauskas
Journal:  EMBO J       Date:  2006-04-20       Impact factor: 11.598

4.  A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells.

Authors:  T Takahashi; S Yamaguchi; K Chida; M Shibuya
Journal:  EMBO J       Date:  2001-06-01       Impact factor: 11.598

5.  Platelet-derived growth factor-AA is an essential and autocrine regulator of vascular endothelial growth factor expression in non-small cell lung carcinomas.

Authors:  Yasunori Shikada; Yoshikazu Yonemitsu; Takaomi Koga; Mitsuho Onimaru; Toshiaki Nakano; Shinji Okano; Shihoko Sata; Kazunori Nakagawa; Ichiro Yoshino; Yoshihiko Maehara; Katsuo Sueishi
Journal:  Cancer Res       Date:  2005-08-15       Impact factor: 12.701

6.  Evidence of porcine and human endothelium activation by cancer-associated carbohydrates expressed on glycoproteins and tumour cells.

Authors:  Olga V Glinskii; James R Turk; Kenneth J Pienta; Virginia H Huxley; Vladislav V Glinsky
Journal:  J Physiol       Date:  2004-01-01       Impact factor: 5.182

7.  phospholipase C gamma-1 is required downstream of vascular endothelial growth factor during arterial development.

Authors:  Nathan D Lawson; Joshua W Mugford; Brigid A Diamond; Brant M Weinstein
Journal:  Genes Dev       Date:  2003-06-01       Impact factor: 11.361

8.  Essential role of PDGFRalpha-p70S6K signaling in mesenchymal cells during therapeutic and tumor angiogenesis in vivo: role of PDGFRalpha during angiogenesis.

Authors:  Norifumi Tsutsumi; Yoshikazu Yonemitsu; Yasunori Shikada; Mitsuho Onimaru; Mitsugu Tanii; Shinji Okano; Kazuhiro Kaneko; Mamoru Hasegawa; Makoto Hashizume; Yoshihiko Maehara; Katsuo Sueishi
Journal:  Circ Res       Date:  2004-04-01       Impact factor: 17.367

9.  PDGF-alpha receptor expression following hypoxic-ischemic injury in the neonatal rat brain.

Authors:  Ichiro Morioka; Syuichi Tsuneishi; Satoshi Takada; Masafumi Matsuo
Journal:  Kobe J Med Sci       Date:  2004-01

10.  Continuous real time ex vivo epifluorescent video microscopy for the study of metastatic cancer cell interactions with microvascular endothelium.

Authors:  Olga V Glinskii; Virginia H Huxley; James R Turk; Susan L Deutscher; Thomas P Quinn; Kenneth J Pienta; Vladislav V Glinsky
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

View more
  4 in total

1.  Age-dependent renal cortical microvascular loss in female mice.

Authors:  Victor H Urbieta-Caceres; Farhan A Syed; Jing Lin; Xiang-Yang Zhu; Kyra L Jordan; Caitlin C Bell; Michael D Bentley; Amir Lerman; Sundeep Khosla; Lilach O Lerman
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-02-07       Impact factor: 4.310

2.  Complex Non-sinus-associated Pachymeningeal Lymphatic Structures: Interrelationship With Blood Microvasculature.

Authors:  Olga V Glinskii; Virginia H Huxley; Leike Xie; Filiz Bunyak; Kannappan Palaniappan; Vladislav V Glinsky
Journal:  Front Physiol       Date:  2019-10-31       Impact factor: 4.566

3.  Pulsed estrogen therapy prevents post-OVX porcine dura mater microvascular network weakening via a PDGF-BB-dependent mechanism.

Authors:  Olga V Glinskii; Virginia H Huxley; Vladimir V Glinskii; Leona J Rubin; Vladislav V Glinsky
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

4.  SMYD1, an SRF-Interacting Partner, Is Involved in Angiogenesis.

Authors:  Xiangli Ye; Yu Qian; Qian Wang; Wuzhou Yuan; Xiaoyang Mo; Yongqing Li; Zhigang Jiang; Wei Xu; Yun Deng; Yongqi Wan; Xiongwei Fan; Xiushan Wu; Yuequn Wang
Journal:  PLoS One       Date:  2016-01-22       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.